<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>15</Volume>
				<Issue>5</Issue>
				<PubDate PubStatus="epublish">
					<Year>2014</Year>
					<Month>05</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Meta Analysis of Treatment for Stage IE~IIE Extranodal Natural Killer /T Cell Lymphomas in China</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2297</FirstPage>
			<LastPage>2302</LastPage>
			<ELocationID EIdType="pii">28916</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;br/&gt;&lt;b&gt;Objective&lt;/b&gt;: To evaluate early treatment for extranodal natural killer/T cell lymphoma (ENK/TCL) in Chinaand provide reference for clinical treatment of these patients. &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: Computer-based retrieval was performedin PubMed, CNKI, CBM, VIP and WanFang Data to search for randomized controlled trials (RCTs) of treatmentfor early ENK/TCL, and a meta-analysis was conducted with RevMan 5.0 software. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: A total of 11 RCTs,including 871 patients, were selected, of which the first radiotherapy had a higher complete response (CR) thanthe first chemotherapy [OR=14.16, 95%CI (8.68, 23.10), P&lt;0.00001] and CR was not different between combinedtreatment group and radiotherapy group [OR=1.86, 95%CI (0.47, 3.58), P=0.61], but long-term survival ratewas higher with combined treatment[OR=1.88, 95%CI (1.09, 3.19), P=0.02]. No difference in survival rate wasobserved between radio-chemotherapy and chemo-radiotherapy groups [OR=1.11, 95%CI (0.73, 1.69), P=0.63].&lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: Radiotherapy is of great significance in the treatment of early ENK/TCL, but combined therapycould further enhance long-term survival rate of patients. This conclusion still requires further confirmationusing RCTs with high quality and large sample size.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Extranodal natural killer/T cell lymphoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">radiotherapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Chemotherapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">RCT</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meta Analysis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_28916_d78d347ed295b8318c8606c8c933cae9.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
